MILLIMAN DEMAND INTELLIGENCE ACCELERATOR

Providing temporary use of an interactive and dynamic web-based software application for developing estimates, intended to help primary and secondary insurance payers better understand the potential utilization and costs associated with cell and gene therapies that are in Phase 2 or later clinical development